Study identifies an intestinal immune cell that impacts the gut microbiome, affecting brain functions linked to depression and stress.
Study Investigates the Source of Back and Joint Pain With the Goal of Reverse Engineering Treatments
Researchers investigate the degeneration process of musculoskeletal tissues that leads to chronic back and joint pain with the hope to translate their findings into new methods to repair tissue damage and ultimately relieve pain.
Study reveals an association between depression and other mental health problems and an increased risk of cardiovascular disease in younger people.
People with diabetes who experience low blood sugar are more likely to experience worsening diabetic retinopathy.
A single psychedelic experience increases beliefs about consciousness, meaning, purpose, and a range of nonphysicalist beliefs.
TRPM7 plays a role in suppressing breathing in obese mice with symptoms of sleep apnea.
A neuroimaging study reveals distinctive changes in white matter and other brain tissue physiology in Lyme disease patients during the post-treatment phase. The study also found unusual activity in the frontal lobe, a brain area associated with memory recall and concentration in those who had been treated for Lyme.
Stress impacts the brain's response to food, researchers report. Additionally, both lean and obese people react to food cues in brain areas associated with reward and cognitive control.
The primary motor and primary somatosensory areas of the brain are involved in controlling immediate motor movements in real-time, while the premotor area appears to control planned, sequential movements as well as reacting to and adjusting the sequence when faced with unexpected changes.
Anosmia, the loss of the sense of smell which is a common symptom of COVID-19, may be a secondary consequence of immune system inflammation rather than a direct action of the virus.
When beliefs change following psychedelic use in relation to mystical experiences, attributions of consciousness tend to increase.
The antidepressant effect of psilocybin-assisted therapy, in combination with psychotherapy, appears to provide up to a year of symptom relief for some patients with major depressive disorder.
